Suzanne Louise Warpula, FNP | |
60 Livingston St Ste 200, Asheville, NC 28801-4400 | |
(828) 253-4851 | |
Not Available |
Full Name | Suzanne Louise Warpula |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Location | 60 Livingston St Ste 200, Asheville, North Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093201584 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 5010691 (North Carolina) | Secondary |
363L00000X | Nurse Practitioner | 5010691 (North Carolina) | Primary |
Entity Name | Asheville Internal Medicine, P.a. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699878207 PECOS PAC ID: 6002889896 Enrollment ID: O20040819000092 |
News Archive
Oncologists at the Fred Hutchinson Cancer Research Center have successfully treated a patient with metastatic melanoma by combining two different types of immunotherapy. Cassian Yee and colleagues describe their approach in a paper, "Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient," that will be published online May 30 in The Journal of Experimental Medicine.
Dr. Eric J. Topol, chief academic officer of Scripps Health and chief medical officer of the West Wireless Health Institute (WWHI), will join Qualcomm chairman and CEO Dr. Paul E. Jacobs during Jacobs' keynote at International CES on Friday, January 8, 2010, to highlight a variety of digital medical devices that offer physicians and consumers the ability to remotely monitor fitness, sleep, vital signs and pre-natal activity.
Increasingly, Big Pharma is betting on new blockbuster cancer drugs that cost billions to develop and can be sold for thousands of dollars a dose. In 2010, each of the top 10 cancer drugs topped more than $1 billion in sales, according to Campbell Alliance, a health-care consulting firm. A decade earlier, only two of them did.
News outlets report on how their local hospitals were graded by a nonprofit organization that culled patient safety ratings from a variety of sources and assigned a single letter grade to more than 2,600 hospitals in the United States.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Suzanne Louise Warpula, FNP 60 Livingston St Ste 200, Asheville, NC 28801-4400 Ph: (828) 253-4851 | Suzanne Louise Warpula, FNP 60 Livingston St Ste 200, Asheville, NC 28801-4400 Ph: (828) 253-4851 |
News Archive
Oncologists at the Fred Hutchinson Cancer Research Center have successfully treated a patient with metastatic melanoma by combining two different types of immunotherapy. Cassian Yee and colleagues describe their approach in a paper, "Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient," that will be published online May 30 in The Journal of Experimental Medicine.
Dr. Eric J. Topol, chief academic officer of Scripps Health and chief medical officer of the West Wireless Health Institute (WWHI), will join Qualcomm chairman and CEO Dr. Paul E. Jacobs during Jacobs' keynote at International CES on Friday, January 8, 2010, to highlight a variety of digital medical devices that offer physicians and consumers the ability to remotely monitor fitness, sleep, vital signs and pre-natal activity.
Increasingly, Big Pharma is betting on new blockbuster cancer drugs that cost billions to develop and can be sold for thousands of dollars a dose. In 2010, each of the top 10 cancer drugs topped more than $1 billion in sales, according to Campbell Alliance, a health-care consulting firm. A decade earlier, only two of them did.
News outlets report on how their local hospitals were graded by a nonprofit organization that culled patient safety ratings from a variety of sources and assigned a single letter grade to more than 2,600 hospitals in the United States.
› Verified 5 days ago